SARVARI YELLAPRAGADA to Middle Aged
This is a "connection" page, showing publications SARVARI YELLAPRAGADA has written about Middle Aged.
Connection Strength
0.070
-
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States. Clin Lymphoma Myeloma Leuk. 2024 08; 24(8):523-530.
Score: 0.015
-
Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer. Sci Rep. 2024 01 31; 14(1):2612.
Score: 0.014
-
Disparities in mortality among acute myeloid leukemia-related hospitalizations. Cancer Med. 2023 02; 12(3):3387-3394.
Score: 0.013
-
With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019 06 13; 133(24):2615-2618.
Score: 0.010
-
Nivolumab Treatment for Cancers in the HIV-infected Population. J Immunother. 2018 Oct; 41(8):379-383.
Score: 0.010
-
A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. Br J Haematol. 2015 Apr; 169(1):36-43.
Score: 0.008